Please assess the completion status of the following clinical trial:

Trial Title: Sinusitis and Facial Pain Disorders Anti-Depression Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* meet diagnostic criteria for chronic sinusitis~* meet diagnostic criteria for facial pain disorder~* meet criteria for major depressive disorder on the PHQ-9~* 18 years of age or older~* established primary care provider~* able to read and speak English~Exclusion Criteria:~* unable to give informed consent of unable to complete self-administered questionnaires due to cognitive impairment, language barriers or severe medical condition~* terminal illness or significantly immunocompromized~* complications from chronic rhinosinusitis~* presence of sinus tumor~* isolated sphenoid disease~* immotile cilia syndrome~* currently on anti-depressant or mood stabilizer med.~* diagnosis of bipolar disorder, schizophrenic disorders, paranoid disorders, or psychotic disorders NOS~* significant suicide risk~* history of hospitalization for mental disorders including psychosis or depression~* history of drug abuse within prev. 6 months or dependency on any drug, including alcohol~* pregnant or breast feeding~* women of child-bearing potential not currently using an approved method of birth control

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): escitalopram 10mg - 30mg daily
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).